Back to Results
First PageMeta Content
Hoffmann-La Roche / Pharmaceutical sciences / Organic chemistry / Sanofi / Diabetes management / Pharmaceutical industry / Diabetes mellitus / Pitavastatin / SLC5A2 / Chemistry / Diabetes / Chugai Pharmaceutical Co.


License Agreement of SGLT2 Inhibitor “CSG452” in Japan
Add to Reading List

Document Date: 2012-10-26 01:56:33

Open Document

File Size: 80,72 KB

Share Result on Facebook
UPDATE